ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab for Advanced RCC With Variant Histology"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab for Advanced RCC With Variant Histology"

By Insights from 2023 ASCO® Annual Meeting FEATURING Bradley McGregor

688 views

June 8, 2023

0 Comments

All Things PSA

Feat. J. Hamilton, M. Fabrizio, M. Taha

Primary Analysis and Follow-up Data of a Combination Therapy in 1L a…

Feat. S. Ratnam

Recent GU Developments and Their Clinical Implications

Feat. T. Powles, B. Rini

13:37

SIR 2023 Conference Coverage

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

Feat. N. Kothary

15:58

Total Health

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Feat. M. Reimers

17:50

AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde

07:27

Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

19:41

Balazs Halmos

How I Manage Immune Adverse Events in Solid Tumors

29:25

Young Chae

Hyperprogression in Cancer Treated With Immunotherapy

16:19

OncoAlert

Year in Review: RCC Practice Changing and Practice Informing Trials …

Feat. T. Choueiri

07:10

Viktor Grünwald

Updated Results From the CLEAR Trial: Outcomes of the Combination of…

09:54

Insights from 2024 ASCO® GU Annual Meeting

The Impact of Immunotherapy-Based Regimens in Primary Renal Tumors

Feat. R. McKay

15:17

ASCO GU 2023 Conference Coverage

ASCO GU 2023 Systemic Therapy for Recurrent Metastatic RCC: Beyond S…

Feat. T. Zhang

22:03

Dana-Farber Cancer Institute

RCC Highlights From ASCO® GU 2024

Feat. W. Xu, T. Choueiri

15:44

Matthew Campbell

How to Select Frontline Therapy for Metastatic Clear Cell RCC

09:35

Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "State-of-the-Art in Adjuvant Treatment of …

Feat. G. de Velasco

23:16

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Optimizing Therapy Selection for Patients…

Feat. B. McGregor

19:42

International Urology Cancer Summit - IUCS

How to Choose 1L Therapy for mRCC

Feat. M. Pal

10:27

Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

09:03

Insights from 2024 ASCO® GU Annual Meeting

ASCO® GU 2024 Insights: "Long-Term Follow-Up Data From the Chec…

Feat. D. McDermott

13:22

OncoAlert

Urology Year in Review: Prostate Cancer Screening, EMBARK Trial, PSM…

Feat. A. Merseburger

15:50

Pavlos Msaouel

Login

Login

Join VuMedi

ASCO® 2023 Insights: "Cabozantinib, Nivolumab, and Ipilimumab for Advanced RCC With Variant Histology"

Related Content